US Stock MarketDetailed Quotes

CSPCY CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS

Watchlist

3.000
+0.110+3.81%

15min DelayClose Apr 22 16:00 ET

8.92BMarket Cap10.99P/E (TTM)

CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

1.66%31.45B

1.93%7.59B

-1.28%7.78B

3.76%8.03B

2.28%8.05B

11.02%30.94B

7.44B

7.89B

7.74B

7.87B

Operating revenue

1.66%31.45B

1.93%7.59B

-1.28%7.78B

3.76%8.03B

2.28%8.05B

11.02%30.94B

--7.44B

--7.89B

--7.74B

--7.87B

Cost of revenue

6.83%9.27B

-2.95%2.2B

4.13%2.23B

4.50%2.31B

22.87%2.53B

28.95%8.68B

2.27B

2.14B

2.21B

2.06B

Gross profit

-0.36%22.18B

4.07%5.38B

-3.30%5.55B

3.46%5.72B

-5.03%5.52B

5.31%22.26B

5.17B

5.74B

5.53B

5.81B

Operating expense

-2.17%15.16B

0.18%3.59B

-6.12%3.77B

3.16%4.02B

-5.51%3.77B

4.10%15.5B

3.59B

4.02B

3.9B

3.99B

Selling and administrative expenses

-10.25%10.33B

-3.16%2.44B

-18.69%2.45B

-7.04%2.69B

-10.81%2.75B

0.50%11.51B

--2.52B

--3.01B

--2.89B

--3.08B

-Selling and marketing expense

-11.58%9.14B

-5.16%2.11B

-21.24%2.13B

-6.63%2.41B

-11.91%2.49B

-1.01%10.34B

--2.22B

--2.7B

--2.59B

--2.82B

-General and administrative expense

1.43%1.19B

11.72%333.68M

3.55%320.33M

-10.50%272.56M

1.07%263.08M

16.14%1.17B

--298.68M

--309.34M

--304.52M

--260.3M

Research and development costs

21.17%4.83B

8.08%1.15B

32.64%1.37B

31.90%1.3B

11.77%1.01B

16.14%3.99B

--1.07B

--1.04B

--982.56M

--901.52M

Other operating expenses

----

54.61%37.51M

79.86%16.64M

----

--24.26M

--9.25M

Operating profit

3.79%7.02B

12.87%1.79B

3.26%1.78B

4.19%1.7B

-3.99%1.74B

8.17%6.76B

1.59B

1.73B

1.63B

1.82B

Net non-operating interest income expense

-4.04%-25.9M

8.82%-9.02M

-16.62%-6.16M

8.32%-6.29M

-54.97%-4.43M

-224.78%-24.89M

-9.89M

-5.28M

-6.86M

-2.86M

Non-operating interest expense

4.04%25.9M

-8.82%9.02M

16.62%6.16M

-8.32%6.29M

54.97%4.43M

224.78%24.89M

--9.89M

--5.28M

--6.86M

--2.86M

Other net income (expense)

Special income (charges)

-31.63%32.86M

--0

----

28.64%48.07M

--48.07M

----

-Less:Other special charges

31.63%-32.86M

--0

----

-28.64%-48.07M

----

Other non- operating income (expenses)

-48.38%420.59M

-96.04%14.72M

-14.66%136.94M

-37.74%210.44M

205.33%58.5M

49.32%814.85M

--371.94M

--160.47M

--337.99M

---55.54M

Income before tax

-2.54%7.39B

-10.36%1.78B

2.69%1.93B

-2.81%1.9B

0.97%1.78B

10.74%7.58B

1.99B

1.88B

1.96B

1.76B

Income tax

-2.48%1.32B

8.59%351.94M

2.24%341.23M

-14.09%311.65M

-5.39%311.86M

16.50%1.35B

324.09M

333.75M

362.75M

329.63M

Net income

-2.56%6.07B

-14.05%1.43B

2.79%1.59B

-0.24%1.59B

2.43%1.47B

9.56%6.23B

1.66B

1.54B

1.59B

1.43B

Net income continuous Operations

-2.56%6.07B

-14.05%1.43B

2.79%1.59B

-0.24%1.59B

2.43%1.47B

9.56%6.23B

--1.66B

--1.54B

--1.59B

--1.43B

Minority interest income

41.74%199.37M

30.47%48.99M

40.47%59.32M

63.30%50.8M

35.22%40.26M

69.59%140.66M

37.55M

42.23M

31.11M

29.77M

Net income attributable to the parent company

-3.58%5.87B

-15.08%1.38B

1.73%1.53B

-1.51%1.54B

1.73%1.43B

8.67%6.09B

1.62B

1.5B

1.56B

1.4B

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-3.58%5.87B

-15.08%1.38B

1.73%1.53B

-1.51%1.54B

1.73%1.43B

8.67%6.09B

1.62B

1.5B

1.56B

1.4B

Basic earnings per share

-3.21%1.9788

-14.61%0.4652

2.30%0.5156

-1.07%0.5184

1.70%0.4796

9.00%2.0444

0.5448

0.504

0.524

0.4716

Diluted earnings per share

-3.21%1.9788

-14.61%0.4652

2.22%0.5152

-1.07%0.5184

1.70%0.4796

9.00%2.0444

0.5448

0.504

0.524

0.4716

Dividend per share

30.73%0.9184

43.51%0.5211

17.06%0.3974

25.14%0.7025

0.3631

0.3394

Currency Unit

CNY

Accounting Standards

NonUS-GAAP

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	1.66%31.45B	1.93%7.59B	-1.28%7.78B	3.76%8.03B	2.28%8.05B	11.02%30.94B	7.44B	7.89B	7.74B	7.87B
Operating revenue	1.66%31.45B	1.93%7.59B	-1.28%7.78B	3.76%8.03B	2.28%8.05B	11.02%30.94B	--7.44B	--7.89B	--7.74B	--7.87B
Cost of revenue	6.83%9.27B	-2.95%2.2B	4.13%2.23B	4.50%2.31B	22.87%2.53B	28.95%8.68B	2.27B	2.14B	2.21B	2.06B
Gross profit	-0.36%22.18B	4.07%5.38B	-3.30%5.55B	3.46%5.72B	-5.03%5.52B	5.31%22.26B	5.17B	5.74B	5.53B	5.81B
Operating expense	-2.17%15.16B	0.18%3.59B	-6.12%3.77B	3.16%4.02B	-5.51%3.77B	4.10%15.5B	3.59B	4.02B	3.9B	3.99B
Selling and administrative expenses	-10.25%10.33B	-3.16%2.44B	-18.69%2.45B	-7.04%2.69B	-10.81%2.75B	0.50%11.51B	--2.52B	--3.01B	--2.89B	--3.08B
-Selling and marketing expense	-11.58%9.14B	-5.16%2.11B	-21.24%2.13B	-6.63%2.41B	-11.91%2.49B	-1.01%10.34B	--2.22B	--2.7B	--2.59B	--2.82B
-General and administrative expense	1.43%1.19B	11.72%333.68M	3.55%320.33M	-10.50%272.56M	1.07%263.08M	16.14%1.17B	--298.68M	--309.34M	--304.52M	--260.3M
Research and development costs	21.17%4.83B	8.08%1.15B	32.64%1.37B	31.90%1.3B	11.77%1.01B	16.14%3.99B	--1.07B	--1.04B	--982.56M	--901.52M
Other operating expenses	----	----	----	54.61%37.51M	79.86%16.64M	----	----	----	--24.26M	--9.25M
Operating profit	3.79%7.02B	12.87%1.79B	3.26%1.78B	4.19%1.7B	-3.99%1.74B	8.17%6.76B	1.59B	1.73B	1.63B	1.82B
Net non-operating interest income expense	-4.04%-25.9M	8.82%-9.02M	-16.62%-6.16M	8.32%-6.29M	-54.97%-4.43M	-224.78%-24.89M	-9.89M	-5.28M	-6.86M	-2.86M
Non-operating interest expense	4.04%25.9M	-8.82%9.02M	16.62%6.16M	-8.32%6.29M	54.97%4.43M	224.78%24.89M	--9.89M	--5.28M	--6.86M	--2.86M
Other net income (expense)
Special income (charges)	-31.63%32.86M	--0	----	----	----	28.64%48.07M	--48.07M	----	----	----
-Less:Other special charges	31.63%-32.86M	--0	----	----	----	-28.64%-48.07M	----	----	----	----
Other non- operating income (expenses)	-48.38%420.59M	-96.04%14.72M	-14.66%136.94M	-37.74%210.44M	205.33%58.5M	49.32%814.85M	--371.94M	--160.47M	--337.99M	---55.54M
Income before tax	-2.54%7.39B	-10.36%1.78B	2.69%1.93B	-2.81%1.9B	0.97%1.78B	10.74%7.58B	1.99B	1.88B	1.96B	1.76B
Income tax	-2.48%1.32B	8.59%351.94M	2.24%341.23M	-14.09%311.65M	-5.39%311.86M	16.50%1.35B	324.09M	333.75M	362.75M	329.63M
Net income	-2.56%6.07B	-14.05%1.43B	2.79%1.59B	-0.24%1.59B	2.43%1.47B	9.56%6.23B	1.66B	1.54B	1.59B	1.43B
Net income continuous Operations	-2.56%6.07B	-14.05%1.43B	2.79%1.59B	-0.24%1.59B	2.43%1.47B	9.56%6.23B	--1.66B	--1.54B	--1.59B	--1.43B
Minority interest income	41.74%199.37M	30.47%48.99M	40.47%59.32M	63.30%50.8M	35.22%40.26M	69.59%140.66M	37.55M	42.23M	31.11M	29.77M
Net income attributable to the parent company	-3.58%5.87B	-15.08%1.38B	1.73%1.53B	-1.51%1.54B	1.73%1.43B	8.67%6.09B	1.62B	1.5B	1.56B	1.4B
Preferred stock dividends
Other preferred stock dividends	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-3.58%5.87B	-15.08%1.38B	1.73%1.53B	-1.51%1.54B	1.73%1.43B	8.67%6.09B	1.62B	1.5B	1.56B	1.4B
Basic earnings per share	-3.21%1.9788	-14.61%0.4652	2.30%0.5156	-1.07%0.5184	1.70%0.4796	9.00%2.0444	0.5448	0.504	0.524	0.4716
Diluted earnings per share	-3.21%1.9788	-14.61%0.4652	2.22%0.5152	-1.07%0.5184	1.70%0.4796	9.00%2.0444	0.5448	0.504	0.524	0.4716
Dividend per share	30.73%0.9184	0	43.51%0.5211	17.06%0.3974	0	25.14%0.7025	0	0.3631	0.3394	0
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall